Aortic calcifications in familial hypercholesterolemia

Potential role of the low-density lipoprotein receptor gene

Khalid Alrasadi, Khalid Alwaili, Zuhier Awan, David Valenti, Patrick Couture, Jacques Genest

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: We have previously reported premature, extensive aortic calcifications in patients with homozygous familial hypercholesterolemia (hmzFH) due to mutations in the low-density lipoprotein receptor gene (LDL-R). The objective of this study was to measure the degree of aortic calcification in heterozygous FH (htzFH) compared to both hmzFH and controls. We hypothesized that the LDL-R gene may contribute to aortic calcifications in a gene-dosage effect. Method: Patients with htzFH due to the French Canadian mutation (Δ15 kb del. null allele) were selected. All patients underwent computed tomographic scan to measure vascular calcification. We used 22 hmzFH patients from our previous study and patients undergoing computed tomographic virtual colonoscopy as controls. Results: Mean age for htzFH was 50 ± 15 years; initial cholesterol level before treatment was 10.45 ± 1.73 mmol/L. Major cardiovascular events occurred in 9 of 17 patients. A strong correlation between age and calcium score was found (r = 0.72, P = .0016). There was a strong correlation between the cholesterol-year score (an index of lifelong cholesterol burden) and the aortic calcium score (r = 0.62, P = .0105). Aortic calcifications in htzFH subjects occurred later than in hmzFH patients, but much earlier than in controls, suggesting a gene-dosage effect of LDL-R mutations and aortic calcium deposition. Conclusion: Aortic calcification was observed in patients with htzFH but presented at a later time and were less extensive than in hmzFH (34 vs 14 years, respectively). Because aortic calcifications may be partly independent of serum cholesterol levels in patients with familial hypercholesterolemia, implications for screening and the timing of treatment initiation may need reassessment.

Original languageEnglish
Pages (from-to)170-176
Number of pages7
JournalAmerican Heart Journal
Volume157
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Hyperlipoproteinemia Type II
LDL Receptors
Genes
Cholesterol
Gene Dosage
Calcium
Mutation
Computed Tomographic Colonography
Vascular Calcification
Alleles

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Aortic calcifications in familial hypercholesterolemia : Potential role of the low-density lipoprotein receptor gene. / Alrasadi, Khalid; Alwaili, Khalid; Awan, Zuhier; Valenti, David; Couture, Patrick; Genest, Jacques.

In: American Heart Journal, Vol. 157, No. 1, 01.2009, p. 170-176.

Research output: Contribution to journalArticle

Alrasadi, Khalid ; Alwaili, Khalid ; Awan, Zuhier ; Valenti, David ; Couture, Patrick ; Genest, Jacques. / Aortic calcifications in familial hypercholesterolemia : Potential role of the low-density lipoprotein receptor gene. In: American Heart Journal. 2009 ; Vol. 157, No. 1. pp. 170-176.
@article{5235edff4f2842b19f2fb0814f298364,
title = "Aortic calcifications in familial hypercholesterolemia: Potential role of the low-density lipoprotein receptor gene",
abstract = "Background: We have previously reported premature, extensive aortic calcifications in patients with homozygous familial hypercholesterolemia (hmzFH) due to mutations in the low-density lipoprotein receptor gene (LDL-R). The objective of this study was to measure the degree of aortic calcification in heterozygous FH (htzFH) compared to both hmzFH and controls. We hypothesized that the LDL-R gene may contribute to aortic calcifications in a gene-dosage effect. Method: Patients with htzFH due to the French Canadian mutation (Δ15 kb del. null allele) were selected. All patients underwent computed tomographic scan to measure vascular calcification. We used 22 hmzFH patients from our previous study and patients undergoing computed tomographic virtual colonoscopy as controls. Results: Mean age for htzFH was 50 ± 15 years; initial cholesterol level before treatment was 10.45 ± 1.73 mmol/L. Major cardiovascular events occurred in 9 of 17 patients. A strong correlation between age and calcium score was found (r = 0.72, P = .0016). There was a strong correlation between the cholesterol-year score (an index of lifelong cholesterol burden) and the aortic calcium score (r = 0.62, P = .0105). Aortic calcifications in htzFH subjects occurred later than in hmzFH patients, but much earlier than in controls, suggesting a gene-dosage effect of LDL-R mutations and aortic calcium deposition. Conclusion: Aortic calcification was observed in patients with htzFH but presented at a later time and were less extensive than in hmzFH (34 vs 14 years, respectively). Because aortic calcifications may be partly independent of serum cholesterol levels in patients with familial hypercholesterolemia, implications for screening and the timing of treatment initiation may need reassessment.",
author = "Khalid Alrasadi and Khalid Alwaili and Zuhier Awan and David Valenti and Patrick Couture and Jacques Genest",
year = "2009",
month = "1",
doi = "10.1016/j.ahj.2008.08.021",
language = "English",
volume = "157",
pages = "170--176",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Aortic calcifications in familial hypercholesterolemia

T2 - Potential role of the low-density lipoprotein receptor gene

AU - Alrasadi, Khalid

AU - Alwaili, Khalid

AU - Awan, Zuhier

AU - Valenti, David

AU - Couture, Patrick

AU - Genest, Jacques

PY - 2009/1

Y1 - 2009/1

N2 - Background: We have previously reported premature, extensive aortic calcifications in patients with homozygous familial hypercholesterolemia (hmzFH) due to mutations in the low-density lipoprotein receptor gene (LDL-R). The objective of this study was to measure the degree of aortic calcification in heterozygous FH (htzFH) compared to both hmzFH and controls. We hypothesized that the LDL-R gene may contribute to aortic calcifications in a gene-dosage effect. Method: Patients with htzFH due to the French Canadian mutation (Δ15 kb del. null allele) were selected. All patients underwent computed tomographic scan to measure vascular calcification. We used 22 hmzFH patients from our previous study and patients undergoing computed tomographic virtual colonoscopy as controls. Results: Mean age for htzFH was 50 ± 15 years; initial cholesterol level before treatment was 10.45 ± 1.73 mmol/L. Major cardiovascular events occurred in 9 of 17 patients. A strong correlation between age and calcium score was found (r = 0.72, P = .0016). There was a strong correlation between the cholesterol-year score (an index of lifelong cholesterol burden) and the aortic calcium score (r = 0.62, P = .0105). Aortic calcifications in htzFH subjects occurred later than in hmzFH patients, but much earlier than in controls, suggesting a gene-dosage effect of LDL-R mutations and aortic calcium deposition. Conclusion: Aortic calcification was observed in patients with htzFH but presented at a later time and were less extensive than in hmzFH (34 vs 14 years, respectively). Because aortic calcifications may be partly independent of serum cholesterol levels in patients with familial hypercholesterolemia, implications for screening and the timing of treatment initiation may need reassessment.

AB - Background: We have previously reported premature, extensive aortic calcifications in patients with homozygous familial hypercholesterolemia (hmzFH) due to mutations in the low-density lipoprotein receptor gene (LDL-R). The objective of this study was to measure the degree of aortic calcification in heterozygous FH (htzFH) compared to both hmzFH and controls. We hypothesized that the LDL-R gene may contribute to aortic calcifications in a gene-dosage effect. Method: Patients with htzFH due to the French Canadian mutation (Δ15 kb del. null allele) were selected. All patients underwent computed tomographic scan to measure vascular calcification. We used 22 hmzFH patients from our previous study and patients undergoing computed tomographic virtual colonoscopy as controls. Results: Mean age for htzFH was 50 ± 15 years; initial cholesterol level before treatment was 10.45 ± 1.73 mmol/L. Major cardiovascular events occurred in 9 of 17 patients. A strong correlation between age and calcium score was found (r = 0.72, P = .0016). There was a strong correlation between the cholesterol-year score (an index of lifelong cholesterol burden) and the aortic calcium score (r = 0.62, P = .0105). Aortic calcifications in htzFH subjects occurred later than in hmzFH patients, but much earlier than in controls, suggesting a gene-dosage effect of LDL-R mutations and aortic calcium deposition. Conclusion: Aortic calcification was observed in patients with htzFH but presented at a later time and were less extensive than in hmzFH (34 vs 14 years, respectively). Because aortic calcifications may be partly independent of serum cholesterol levels in patients with familial hypercholesterolemia, implications for screening and the timing of treatment initiation may need reassessment.

UR - http://www.scopus.com/inward/record.url?scp=57149095250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149095250&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2008.08.021

DO - 10.1016/j.ahj.2008.08.021

M3 - Article

VL - 157

SP - 170

EP - 176

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -